Loading…
Diamyd Medical is setting up a new manufacturing facility in Umeå, Sweden, to produce recombinant GAD65 for its diabetes vaccine Diamyd. Initial investments are estimated at approximately SEK 20 million (about USD 2 million).
| Site | Largest | Latest |
|---|---|---|
| Umeå, Sweden | $2.00M | 2020-04-16 |